Please join us for the Leadiant Meet the Clinicians Reception during the IDF 2019 National Conference. Leadiant will provide a brief corporate overview and an introduction to the new enzyme replacement therapy (ERT) for adenosine deaminase severe combined immune deficiency (ADA-SCID).
Clinicians will have the opportunity to:
Meet with other clinicians to engage in discussion on the following:
- Introduction of a new enzyme replacement therapy (ERT) for ADA-SCID
- Transition from previous treatment to new ERT treatment
- Evolving treatment paradigm
- Insights and feedback from patients on their experience through the transition
- Educational needs and ongoing programs and materials